Compare Edwards Lifesciences Corporation Common Stock (EW) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Liberty Global Ltd Class C — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Liberty Global Ltd Class C trades at $8.79 (market cap $3.12B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 15.8× Liberty Global Ltd Class C's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals.
| EW | LBTYK | |
|---|---|---|
Market Cap | $49.44B | $3.12B |
Volume | 3,508,027 | 1,096,842 |
Sector | Health | Media |
52-Week High | $95.18 | $12.67 |
52-Week Low | $72.65 | $8.75 |
Enterprise Value | $45.90B | $9.78B |
Typical Hold Time | — | 21 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LBTYK is trading at $8.92, down 0.28% on the day, and is near its 52-week low. The stock shows a bearish technical trend with mixed earnings, including a recent Q1 2026 beat but a Q2 2026 miss. Financially, it has a negative net income margin of -62.14% for 2026, though revenue remains stable at $4.9B. Recent news highlights strategic moves like the Ziggo Group spin-off planned for 2027 and an AI partnership to enhance customer experiences.
The outlook is cautious; while analyst consensus is bullish with a $12.67 price target, high losses and bearish technicals pose risks. Upside potential hinges on successful asset monetization and the Ziggo listing, but investors face volatility from ongoing profitability challenges and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
